Lithium Werks Sells Modular Business Unit to Lithion Power Group

Lithium Werks carves out its Valence™ module business to focus on its world-leading Cell manufacturing, LFP patent portfolio, custom solutions, and new R&D.

AUSTIN, Texas and ENSCHEDE, The Netherlands, Dec. 22, 2020 (GLOBE NEWSWIRE) — Lithium Werks, a global leader in Lithium Iron Phosphate cell manufacturing, technology, and intellectual property, announces that it has sold its Valence™ module and BMS assets to Lithion Power Group, a vertically integrated manufacturer of cells and rechargeable and non-rechargeable battery packs.

As a result of the sale, Lithium Werks will concentrate intensely on continuing to develop its “Best in Class” Nanophosphate™ materials, cell production, custom OEM solutions, increasing R&D, and further expanding and strengthening its Lithium Iron Phosphate (LFP) cathode patent portfolio.

Rapidly growing demand exists for Lithium Werks exclusive technologies from diverse industry sectors on a global basis. The transaction will facilitate Lithium Werks’ continued focus on meeting this demand.

T. Joseph Fisher, III, CEO and Co-Founder of Lithium Werks, B.V., stated:

“This move will sharpen our focus on being able to serve our current and future customers with our most powerful and long-lasting Nanophosphate™ powder and cells, not only for our existing verticals like industrial, medical and UPS backup, but with a new strategic clarity for mission critical applications including the energy storage and transportation verticals with custom solutions. We look forward to continued growth and expansion as a provider of our leading-edge Nanophosphate™ cylindrical cells, as well as introducing other new form factors and sizes for those applications that require the Power. Safety. Life. of our MIT developed Nanophosphate™ cathode materials.”

Lithium Werks possesses the world’s most comprehensive portfolio of Lithium Iron Phosphate materials, cells, Intellectual Property LFP patents and products. Lithium Werks operates in China, Europe, and the United States.

For more information, please visit us at

[email protected]

Latest News

U.S. Government to Purchase Minimum of 100,000 Doses of Etesevimab and Bamlanivimab Neutralizing Antibody Therapy

SHANGHAI, China, Feb. 27, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, announced today that the U.S. government has agreed to purchase a minimum of 100,000 doses of etesevimab (JS016 or LY-CoV016) 1400 mg and bamlanivimab (LY-CoV555) 700 […]

Bombardier Challenger 350 Jet Most Delivered in Category for Seventh Consecutive Year, Company Also Ends 2020 With Highest Total Market Share in Fourth Quarter

MONTREAL, Feb. 26, 2021 (GLOBE NEWSWIRE) — Bombardier announced today that its best-selling Challenger 350 aircraft was the most-delivered medium category business jet in 2020, making it the category leader for a seventh consecutive year. As detailed in the General Aviation Manufacturers Association’s (GAMA) annual shipment and billings report released February 24, the company also […]

Colliers ranked among top three commercial real estate brands by Lipsey survey

Ranking reaffirms Colliers’ commitment to leading the industry TORONTO, Feb. 26, 2021 (GLOBE NEWSWIRE) — For the fourth straight year, leading diversified professional services and investment management company Colliers (NASDAQ, TSX: CIGI) has been named one of the top three global commercial real estate brands by The Lipsey Company in its survey of industry professionals. […]